Clinical trial Recruiting at 1 site Interventional Ages 18 to 40 Women only

High-intensity interval training to reduce menstrual pain and improve menstrual health in women with primary dysmenorrhea

Official title: Efficacy of a High-Intensity Interval Training Program and Analysis of Menstrual Health Experience in Women With Primary Dysmenorrhea: A Mixed-Methods Randomized Controlled Trial.

Run by University of Alcala · NCT07391930 · Data updated 2026-11-12

This 12-week program will try supervised online high-intensity interval training plus a menstrual health workshop to see if it reduces menstrual pain and improves quality of life for women aged 18–40 with primary dysmenorrhea.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment60 (estimated)
SponsorUniversity of Alcala
Academic / other
Locations1 site (Alcalá de Henares, Madrid)
StatusRecruiting
StartedFebruary 18, 2026
Main results expectedJune 2028
Study endsJune 2029
Registry record updatedApril 21, 2026
Trial IDNCT07391930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are nulliparous women aged 18–40 with primary dysmenorrhea, BMI 18–30, menstrual pain >5 on the numeric pain scale, currently doing 45–75 minutes of exercise per week, able to perform high-intensity exercise, and able to read and consent in Spanish.

Probably not a fit

Patients with secondary dysmenorrhea, amenorrhea or very long cycles, current hormonal drug use, recent pelvic surgery, fibromyalgia or other comorbidities that prevent intense exercise, or those already doing very high levels of intense exercise are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, convergent mixed-methods study enrolling 50 nulliparous women with primary dysmenorrhea who meet BMI and pain thresholds. Participants are randomized to 12 weeks of supervised online HIIT (two sessions per week) plus a menstrual health educational workshop or to the workshop alone. Clinical outcomes (pain intensity by NRS, quality of life by SF-12, and pain characteristics by the McGill questionnaire) are collected at baseline, 3 months (post-intervention), and 6 months (follow-up). All participants also complete weekly semi-structured digital diaries for thematic analysis, and quantitative and qualitative data will be merged for a holistic interpretation.

Why it matters

Potential benefit: If successful, this could provide a non-pharmacological option that reduces menstrual pain and improves daily functioning and quality of life.

How similar studies have gone: Prior exercise interventions have shown some benefit for menstrual pain, but supervised online HIIT combined with qualitative diary integration for primary dysmenorrhea is relatively novel and not yet well-established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* nulliparous
* primary dysmenorrhea
* body mass index between 18 and 30
* menstrual pain \>5 according to the Numeric Pain Scale
* exercise \>45 minutes/week
* understand Spanish and can freely read and sign the informed consent form

Exclusion Criteria:

* amenorrhea or cycles \>35 days
* secondary dysmenorrhea
* pelvic or abdominal surgical intervention
* use of hormonal drugs
* diagnosed with fibromyalgia, muscoloskeletal injuries or medical comorbidities that prevent them from performing intense exercise
* receiving physiotherapy for pelvic floor disorders
* intense exercise \>75 minutes/week

Where it's running

  • Universidad de Alcalá, Facultad de Enfermeria y Fisioterapia
    Alcalá de Henares, Madrid, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.